Brighton Jones LLC Exact Sciences Corp Transaction History

Brighton Jones LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 07, 2018	SELL	$48.29 - $80.6 $556,011 - $928,028	-11,514 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$37.84 - $69.96 $946 - $1,748	-25 Reduced 0.22%	11,514 $688,000
Q1 2018 May 03, 2018	SELL	$39.82 - $57.53 $37,032 - $53,502	-930 Reduced 7.46%	11,539 $465,000
Q4 2017 Feb 08, 2018	SELL	$46.49 - $60.51 $45,885 - $59,723	-987 Reduced 7.34%	12,469 $655,000
Q3 2017 Nov 08, 2017	SELL	$37.05 - $47.12 $162,501 - $206,668	-4,386 Reduced 24.58%	13,456 $634,000
Q2 2017 Aug 08, 2017	BUY	N/A	17,842	17,842 $631,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.